Polyphenol-rich virgin olive oil reduces insulin resistance and liver inflammation and improves mitochondrial dysfunction in high-fat diet fed rats

Molecular Nutrition and Food Research

Volumn 61, Issue 3, 2017, Pages

  Lama, Adriano ^a   Pirozzi, Claudio ^a   Mollica, Maria Pia ^a   Trinchese, Giovanna ^a   Di Guida, Francesca ^a   Cavaliere, Gina ^a   Calignano, Antonio ^a   Mattace Raso, Giuseppina ^a   Berni Canani, Roberto ^a   Meli, Rosaria ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Inflammation; Mediterranean diet; Mitochondrial and hepatic oxidative stress; Nonalcoholic Fatty liver disease; Olive oil polyphenols

Indexed keywords

ADIPOCYTOKINE; CYTOKINE; GLUCOSE; OLIVE OIL; POLYPHENOL; TOCOPHEROL;

ANIMAL; BLOOD; CHEMISTRY; DIET THERAPY; DISEASE MODEL; DRUG EFFECTS; HEPATITIS; INSULIN RESISTANCE; LIPID DIET; LIPID METABOLISM; LIVER MITOCHONDRION; MALE; METABOLISM; NONALCOHOLIC FATTY LIVER; OXIDATIVE STRESS; PATHOPHYSIOLOGY; SPRAGUE DAWLEY RAT;

ADIPOKINES; ANIMALS; CYTOKINES; DIET, HIGH-FAT; DISEASE MODELS, ANIMAL; GLUCOSE; HEPATITIS; INSULIN RESISTANCE; LIPID METABOLISM; MALE; MITOCHONDRIA, LIVER; NON-ALCOHOLIC FATTY LIVER DISEASE; OLIVE OIL; OXIDATIVE STRESS; POLYPHENOLS; RATS, SPRAGUE-DAWLEY; TOCOPHEROLS;

EID: 85007043667     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201600418     Document Type: Article

References (57)

1. Review, T., LaBrecque, D. R., Abbas, Z., Anania, F. et al., World gastroenterology organisation global guidelines: nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. J. Clin. Gastroenterol. 2014, 48, 467–473.
2. Tilg, H., Moschen, A., Weight loss: cornerstone in the treatment of nonalcoholic fatty liver disease. Minerva Gastroenterol. Dietol. 2010, 56, 159–167.
3. Ashraf, N. U., Sheikh, T. A., Endoplasmic reticulum stress and oxidative stress in the pathogenesis of nonalcoholic fatty liver disease. Free Radic. Res. 2015, 49, 1405–1418.
4. Begriche, K., Massart, J., Robin, M. A., Bonnet, F. et al., Mitochondrial adaptations and dysfunctions in nonalcoholic fatty liver disease. Hepatology 2013, 58, 1497–1507.
5. Serviddio, G., Bellanti, F., Vendemiale, G., Free radical biology for medicine: learning from nonalcoholic fatty liver disease. Free Radic. Biol. Med. 2013, 65, 952–968.
6. Asrih, M., Jornayvaz, F. R., Inflammation as a potential link between nonalcoholic fatty liver disease and insulin resistance. J. Endocrinol. 2013, 218, R25–R36.
7. Polyzos, S. A., Kountouras, J., Mantzoros, C. S., Adipokines in nonalcoholic fatty liver disease. Metabolism 2015, 65, 1062–1079.
8. Berlanga, A., Guiu-Jurado, E., Porras, J. A., Auguet, T., Molecular pathways in nonalcoholic fatty liver disease. Clin. Exp. Gastroenterol. 2014, 7, 221–239.
9. Meli, R., Mattace Raso, G., Calignano, A., Role of innate immune response in nonalcoholic fatty liver disease: metabolic complications and therapeutic tools. Front. Immunol. 2014, 5, 177.
10. Federico, A., Zulli, C., de Sio, I., Del Prete, A. et al., Focus on emerging drugs for the treatment of patients with nonalcoholic fatty liver disease. World J. Gastroenterol. 2014, 20, 16841–16857.
11. Ryan, M. C., Itsiopoulos, C., Thodis, T., Ward, G. et al., The Mediterranean diet improves hepatic steatosis and insulin sensitivity in individuals with nonalcoholic fatty liver disease. J. Hepatol. 2013, 59, 138–143.
12. Cicerale, S., Lucas, L., Keast, R., Biological activities of phenolic compounds present in virgin olive oil. Int. J. Mol. Sci. 2010, 11, 458–479.
13. Lewandowska, U., Szewczyk, K., Hrabec, E., Janecka, A. et al., Overview of metabolism and bioavailability enhancement of polyphenols. J. Agric. Food Chem. 2013, 61, 12183–12199.
14. Ryu, S. J., Choi, H. S., Yoon, K. Y., Lee, O. H. et al., Oleuropein suppresses LPS-induced inflammatory responses in RAW 264.7 cell and zebrafish. J. Agric. Food Chem. 2015, 63, 2098–2105.
15. Iacono, A., Gomez, R., Sperry, J., Conde, J. et al., Effect of oleocanthal and its derivatives on inflammatory response induced by lipopolysaccharide in a murine chondrocyte cell line. Arthritis Rheum. 2010, 62, 1675–1682.
16. Scotece, M., Gomez, R., Conde, J., Lopez, V. et al., Oleocanthal inhibits proliferation and MIP-1alpha expression in human multiple myeloma cells. Curr. Med. Chem. 2013, 20, 2467–2475.
17. Lee, H., Im, S. W., Jung, C. H., Jang, Y. J. et al., Tyrosol, an olive oil polyphenol, inhibits ER stress-induced apoptosis in pancreatic beta-cell through JNK signaling. Biochem. Biophys. Res. Commun. 2016, 469, 748–752.
18. Pirozzi, C., Lama, A., Simeoli, R., Paciello, O. et al., Hydroxytyrosol prevents metabolic impairment reducing hepatic inflammation and restoring duodenal integrity in a rat model of NAFLD. J. Nutr. Biochem. 2016, 30, 108–115.
19. Surwit, R. S., Feinglos, M. N., Rodin, J., Sutherland, A. et al., Differential effects of fat and sucrose on the development of obesity and diabetes in C57BL/6J and A/J mice. Metabolism 1995, 44, 645–651.
20. Reagan-Shaw, S., Nihal, M., Ahmad, N., Dose translation from animal to human studies revisited. FASEB J. 2008, 22, 659–661.
21. Raso, G. M., Simeoli, R., Iacono, A., Santoro, A. et al., Effects of a Lactobacillus paracasei B21060 based synbiotic on steatosis, insulin signaling and toll-like receptor expression in rats fed a high-fat diet. J. Nutr. Biochem. 2014, 25, 81–90.
22. Mattace Raso, G., Simeoli, R., Russo, R., Iacono, A. et al., Effects of sodium butyrate and its synthetic amide derivative on liver inflammation and glucose tolerance in an animal model of steatosis induced by high-fat diet. PLoS One 2013, 8, e68626.
23. Ilagan, J., Bhutani, V., Archer, P., Lin, P. K. et al., Estimation of body composition changes during weight cycling by bioelectrical impedance analysis in rats. J. Appl. Physiol. (1985) 1993, 74, 2092–2098.
24. Folch, J., Lees, M., Sloane Stanley, G. H., A simple method for the isolation and purification of total lipides from animal tissues. J. Biol. Chem. 1957, 226, 497–509.
25. Lionetti, L., Crescenzo, R., Mollica, M. P., Tasso, R. et al., Modulation of hepatic mitochondrial energy efficiency with age. Cell. Mol. Life Sci. 2004, 61, 1366–1371.
26. Hartree, E. F., Determination of protein: a modification of the Lowry method that gives a linear photometric response. Anal. Biochem. 1972, 48, 422–427.
27. Cairns, C. B., Walther, J., Harken, A. H., Banerjee, A., Mitochondrial oxidative phosphorylation thermodynamic efficiencies reflect physiological organ roles. Am. J. Physiol. 1998, 274, R1376–R1383.
28. Barja, G., Mitochondrial free radical production and aging in mammals and birds. Ann. N. Y. Acad. Sci. 1998, 854, 224–238.
29. Hausladen, A., Fridovich, I., Measuring nitric oxide and superoxide: rate constants for aconitase reactivity. Methods Enzymol. 1996, 269, 37–41.
30. Montoliu, C., Valles, S., Renau-Piqueras, J., Guerri, C., Ethanol-induced oxygen radical formation and lipid peroxidation in rat brain: effect of chronic alcohol consumption. J. Neurochem. 1994, 63, 1855–1862.
31. Mullane, K. M., Westlin, W., Kraemer, R., Activated neutrophils release mediators that may contribute to myocardial injury and dysfunction associated with ischemia and reperfusion. Ann. N. Y. Acad. Sci. 1988, 524, 103–121.
32. Chung, M. Y., Yeung, S. F., Park, H. J., Volek, J. S. et al., Dietary alpha- and gamma-tocopherol supplementation attenuates lipopolysaccharide-induced oxidative stress and inflammatory-related responses in an obese mouse model of nonalcoholic steatohepatitis. J. Nutr. Biochem. 2010, 21, 1200–1206.
33. Gerber, M., Hoffman, R., The Mediterranean diet: health, science, and society. Br. J. Nutr. 2015, 113(Suppl 2), S4–S10.
34. Maiorino, M. I., Bellastella, G., Petrizzo, M., Scappaticcio, L. et al., Anti-inflammatory effect of mediterranean diet in type 2 diabetes is durable: 8-year follow-up of a controlled trial. Diabetes Care 2016, 39, e44–e45.
35. Papamiltiadous, E. S., Roberts, S. K., Nicoll, A. J., Ryan, M. C. et al., A randomised controlled trial of a Mediterranean Dietary Intervention for Adults with Non Alcoholic Fatty Liver Disease (MEDINA): study protocol. BMC Gastroenterol. 2016, 16, 14.
36. Tektonidis, T. G., Akesson, A., Gigante, B., Wolk, A. et al., Adherence to a Mediterranean diet is associated with reduced risk of heart failure in men. Eur. J. Heart Fail 2016, 18, 253–259.
37. Covas, M. I., de la Torre, R., Fito, M., Virgin olive oil: a key food for cardiovascular risk protection. Br. J. Nutr. 2015, 113(Suppl 2), S19–S28.
38. Calabriso, N., Massaro, M., Scoditti, E., D'Amore, S. et al., Extra virgin olive oil rich in polyphenols modulates VEGF-induced angiogenic responses by preventing NADPH oxidase activity and expression. J. Nutr. Biochem. 2016, 28, 19–29.
39. Kim, Y., Keogh, J. B., Clifton, P. M., Polyphenols and glycemic control. Nutrients 2016, 8, 17.
40. Wu, X., Chen, K., Williams, K. J., The role of pathway-selective insulin resistance and responsiveness in diabetic dyslipoproteinemia. Curr. Opin. Lipidol. 2012, 23, 334–344.
41. Dolinsky, V. W., Rueda-Clausen, C. F., Morton, J. S., Davidge, S. T. et al., Continued postnatal administration of resveratrol prevents diet-induced metabolic syndrome in rat offspring born growth restricted. Diabetes 2011, 60, 2274–2284.
42. Hui, E., Xu, A., Bo Yang, H., Lam, K. S., Obesity as the common soil of nonalcoholic fatty liver disease and diabetes: role of adipokines. J. Diabetes Investig. 2013, 4, 413–425.
43. Park, H. J., Jung, U. J., Lee, M. K., Cho, S. J. et al., Modulation of lipid metabolism by polyphenol-rich grape skin extract improves liver steatosis and adiposity in high fat fed mice. Mol. Nutr. Food Res. 2013, 57, 360–364.
44. Chen, S., Zhao, X., Ran, L., Wan, J. et al., Resveratrol improves insulin resistance, glucose and lipid metabolism in patients with nonalcoholic fatty liver disease: a randomized controlled trial. Dig. Liver Dis. 2015, 47, 226–232.
45. Andrade, J. M., Paraiso, A. F., de Oliveira, M. V., Martins, A. M. et al., Resveratrol attenuates hepatic steatosis in high-fat fed mice by decreasing lipogenesis and inflammation. Nutrition 2014, 30, 915–919.
46. Faghihzadeh, F., Adibi, P., Rafiei, R., Hekmatdoost, A., Resveratrol supplementation improves inflammatory biomarkers in patients with nonalcoholic fatty liver disease. Nutr. Res. 2014, 34, 837–843.
47. Zeng, L., Tang, W. J., Yin, J. J., Zhou, B. J., Signal transductions and nonalcoholic fatty liver: a mini-review. Int. J. Clin. Exp. Med. 2014, 7, 1624–1631.
48. Sinha-Hikim, I., Sinha-Hikim, A. P., Shen, R., Kim, H. J. et al., A novel cystine based antioxidant attenuates oxidative stress and hepatic steatosis in diet-induced obese mice. Exp. Mol. Pathol. 2011, 91, 419–428.
49. Beltran-Debon, R., Rull, A., Rodriguez-Sanabria, F., Iswaldi, I. et al., Continuous administration of polyphenols from aqueous rooibos (Aspalathus linearis) extract ameliorates dietary-induced metabolic disturbances in hyperlipidemic mice. Phytomedicine 2011, 18, 414–424.
50. Kim do, Y., Kim, J., Ham, H. J., Choue, R., Effects of d-alpha-tocopherol supplements on lipid metabolism in a high-fat diet-fed animal model. Nutr. Res. Pract. 2013, 7, 481–487.
51. Raso, G. M., Esposito, E., Iacono, A., Pacilio, M. et al., Comparative therapeutic effects of metformin and vitamin E in a model of nonalcoholic steatohepatitis in the young rat. Eur. J. Pharmacol. 2009, 604, 125–131.
52. Stojsavljevic, S., Gomercic Palcic, M., Virovic Jukic, L., Smircic Duvnjak, L. et al., Adipokines and proinflammatory cytokines, the key mediators in the pathogenesis of nonalcoholic fatty liver disease. World J. Gastroenterol. 2014, 20, 18070–18091.
53. Priore, P., Cavallo, A., Gnoni, A., Damiano, F. et al., Modulation of hepatic lipid metabolism by olive oil and its phenols in nonalcoholic fatty liver disease. IUBMB Life 2015, 67, 9–17.
54. Mantena, S. K., King, A. L., Andringa, K. K., Eccleston, H. B. et al., Mitochondrial dysfunction and oxidative stress in the pathogenesis of alcohol- and obesity-induced fatty liver diseases. Free Radic. Biol. Med. 2008, 44, 1259–1272.
55. Schonfeld, P., Wojtczak, L., Fatty acids as modulators of the cellular production of reactive oxygen species. Free Radic. Biol. Med. 2008, 45, 231–241.
56. Skulachev, V. P., Fatty acid circuit as a physiological mechanism of uncoupling of oxidative phosphorylation. FEBS Lett 1991, 294, 158–162.
57. Magosso, E., Ansari, M. A., Gopalan, Y., Shuaib, I. L. et al., Tocotrienols for normalisation of hepatic echogenic response in nonalcoholic fatty liver: a randomized placebo-controlled clinical trial. Nutr J 2013, 12, 166.